Identification of Small Molecules as Zika Virus Entry Inhibitors
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110726 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Abhijeet Roy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA. Hauptthemen laut MEDLINE: Zika Virus, Virus Internalization, Antiviral Agents, Zika Virus Infection. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Zika virus (ZIKV) caused Zika outbreaks and continues to post threats to public health. ZIKV infection may cause congenital abnormalities during pregnancy and neurological manifestations in adults. The recurrent public health threat of Zika in various geographical areas demonstrates a need for the development of effective therapeutics. Currently, there are no approved therapies for Zika. ZIKV is a single-stranded, positive-sense RNA virus, whose genome encodes three structural proteins and seven non-structural proteins. The surface envelope (E) protein is essential for host–cell recognition and viral entry; therefore, inhibition of E-mediated viral entry is a key strategy underlying antiviral treatments. Here, molecular docking-based virtual screening was used to screen small-molecule compound libraries to identify potential ZIKV entry inhibitors. Among the compounds identified, Pyrimidine-Der1 exhibited efficient inhibition of reporter ZIKV infection. The microscale thermophoresis assay confirmed its binding with the ZIKV E protein. This compound has effective inhibition of authentic ZIKV infection in a plaque inhibition assay against R103451, PAN2016, and FLR human strains (IC50: ~3–5 μM). Additionally, it efficiently inhibited ZIKV infection at viral entry and fusion steps of the virus life cycle in a time-of-addition assay. Overall, Pyrimidine-Der1 is a promising ZIKV entry inhibitor, warranting further optimization and evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
- Department of Chemistry, Georgia State University, Atlanta, GA 30302, USA.
- Lindsey F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA.
- Drug Development Program, Center for Precision Diagnostic and Therapeutic Research, Bengaluru 560100, Karnataka, India.
ORCID-Profile: Abhijeet Roy, Kristin V Lyles, Ming Luo, Asim K Debnath
Zitieren
APA
Roy, A., Cho, H., Lyles, K. V., Lu, W., Luo, M., Debnath, A. K., & Du, L. (2025). Identification of Small Molecules as Zika Virus Entry Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110726
Vancouver
Roy A, Cho H, Lyles KV, Lu W, Luo M, Debnath AK, et al. Identification of Small Molecules as Zika Virus Entry Inhibitors. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110726
BibTeX
@article{Roy2025,
author = {Roy, Abhijeet and Cho, Hansam and Lyles, Kristin V and Lu, Wen and Luo, Ming and Debnath, Asim K and Du, Lanying},
title = {Identification of Small Molecules as Zika Virus Entry Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110726}
}
EUVIMED